Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products

OBJECTIVE: To review primary literature regarding the risk of venous thromboembolism (VTE) in users of combined oral contraceptives (COCs) containing drospirenone compared to COCs containing other progestins. DATA SOURCES: A literature search of MEDLINE and EMBASE (1950-January 2010) was conducted u...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Annals of pharmacotherapy 2010-05, Vol.44 (5), p.898-903
Hauptverfasser:	Sehovic, Naida, Smith, Katherine P
Format:	Artikel
Sprache:	eng
Schlagworte:	Androstenes - adverse effects Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Contraceptives, Oral, Combined - adverse effects Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Humans Incidence Medical sciences Pharmacology. Drug treatments Progesterone Congeners - adverse effects Risk Venous Thromboembolism - chemically induced Venous Thromboembolism - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!